Largest biotech companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Revolution Medicines has the lowest figure of the 21 biotech companies ranked by revenue, at SEK 0, followed by Scholar Rock Holding (SEK 0) and CRISPR Therapeutics (SEK 35.6M). Figures as of 18 Nov 2026, 21:48 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 21
- Lowest
- Revolution MedicinesSEK 0
- Median
- SEK 12.3B
- Combined market value
- SEK 8.48T
- Countries
- 5
- Not ranked
- 3no revenue on file
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Revenue ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Revolution MedicinesRVMD · Health Care | SEK 0 | SEK 350.5B | SEK 1,620.67 | 1.76% down | 131% up | ||
| 2 | Scholar Rock HoldingSRRK · Health Care | SEK 0 | SEK 59.4B | SEK 486.75 | 6.48% up | 14% up | ||
| 3 | CRISPR TherapeuticsCRSP · Health Care | SEK 35.6M | SEK 39.5B | SEK 407.55 | 0.10% up | 21% down | ||
| 4 | CG OncologyCGON · Health Care | SEK 41M | SEK 72.5B | SEK 811.25 | 1.34% up | 85% up | ||
| 5 | Kymera TherapeuticsKYMR · Health Care | SEK 397.6M | SEK 104.9B | SEK 1,228.33 | 0.32% down | 87% up | ||
| 6 | ImmunityBioIBRX · Health Care | SEK 1.1B | SEK 72.3B | SEK 67.94 | 7.03% up | 193% up | ||
| 7 | Adaptive BiotechnologiesADPT · Health Care | SEK 2.8B | SEK 46.7B | SEK 288.60 | 0.11% down | 88% up | ||
| 8 | Twist BioscienceTWST · Health Care | SEK 3.8B | SEK 80.4B | SEK 1,179.86 | 3.88% up | 340% up | ||
| 9 | Krystal BiotechKRYS · Health Care | SEK 3.9B | SEK 94.8B | SEK 3,197.74 | 5.62% up | 46% up | ||
| 10 | RepligenRGEN · Health Care | SEK 7.5B | SEK 111.9B | SEK 1,750.98 | 6.47% up | 5% up | ||
| 11 | Bio-TechneTECH · Health Care | SEK 12.3B | SEK 115.9B | SEK 737.73 | 0.17% up | 26% up | ||
| 12 | Halozyme TherapeuticsHALO · Health Care | SEK 14.2B | SEK 110.8B | SEK 971.47 | 0.18% down | 37% up | ||
| 13 | ModernaMRNA · Health Care | SEK 19.7B | SEK 807.4B | SEK 1,995.57 | 4.84% down | 755% up | ||
| 14 | QiagenQGEN · Health Care | SEK 21.2B | SEK 103.8B | SEK 502.57 | 0.38% down | 12% up | ||
| 15 | ExelixisEXEL · Health Care | SEK 23.5B | SEK 169B | SEK 692.50 | 0.31% down | 63% up | ||
| 16 | Neurocrine BiosciencesNBIX · Health Care | SEK 29B | SEK 167.2B | SEK 1,651.50 | 1.84% down | 20% up | ||
| 17 | BioNTechBNTX · Health Care | SEK 32.3B | SEK 209.3B | SEK 844.31 | 1.89% down | 16% down | ||
| 18 | argenxARGX · Health Care | SEK 42.1B | SEK 600.2B | SEK 9,544.84 | 0.66% down | 4% up | ||
| 19 | BiogenBIIB · Health Care | SEK 100.3B | SEK 376.9B | SEK 2,549.45 | 0.25% up | 49% up | ||
| 20 | Gilead SciencesGILD · Health Care | SEK 298.6B | SEK 2.13T | SEK 1,713.56 | 0.75% down | 33% up | ||
| 21 | AmgenAMGN · Health Care | SEK 372.7B | SEK 2.43T | SEK 4,501.31 | 3.07% down | 34% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1406 SEK). 3 companies have no revenue on file and are not ranked here.
Questions and answers
Which biotech companies have the lowest revenue?
Revolution Medicines (SEK 0), Scholar Rock Holding (SEK 0) and CRISPR Therapeutics (SEK 35.6M) have the lowest revenue of the 21 biotech companies ranked here as of 18 Nov 2026, 21:48 UTC.
How many biotech companies are in this ranking?
21 are ranked by revenue. 3 more have no revenue on file and are left out rather than ranked at zero.
What are these biotech companies worth together?
The 21 biotech companies ranked by revenue have a combined market value of SEK 8.48T as of 18 Nov 2026, 21:48 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech companies by revenue”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.